Fragmentomics of urinary cell-free DNA in nuclease knockout mouse models

Meihui Chen1,2,3, Rebecca W Y Chan1,2,3, Peter P H Cheung2,3

  • 1Centre for Novostics, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong SAR, China.

Plos Genetics
|July 6, 2022
PubMed

Insights

Urinary cell-free DNA (ucfDNA) fragmentation is influenced by deoxyribonuclease 1 (DNASE1), not DNASE1L3. Altered ucfDNA fragmentation patterns, particularly within DNase I hypersensitive sites (DHSs), show promise for bladder cancer detection.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Urinary cell-free DNA (ucfDNA) shows potential as a non-invasive biomarker for bladder cancer.
  • The precise mechanisms governing ucfDNA fragmentation remain incompletely understood.

Purpose of the Study:

  • To investigate the roles of deoxyribonuclease 1 (DNASE1) and deoxyribonuclease 1-like 3 (DNASE1L3) in ucfDNA fragmentation.
  • To explore the potential of ucfDNA fragmentation patterns within DNase I hypersensitive sites (DHSs) for bladder cancer detection.

Main Methods:

  • Utilized mouse models with targeted deletions of Dnase1 and Dnase1l3 genes.
  • Analyzed ucfDNA fragmentation characteristics, including DNA concentration, fragment length, and end-specific features.
  • Compared DNASE1 and DNASE1L3 protein levels and enzymatic activity in urine and plasma.
  • Examined the distribution of ucfDNA fragment ends within DHSs in both mouse models and human bladder cancer patients.

Main Results:

  • Deletion of Dnase1, but not Dnase1l3, significantly altered ucfDNA fragmentation in mice, increasing DNA concentration and favoring longer molecules.
  • DNASE1 exhibited higher concentration and activity in urine compared to DNASE1L3.
  • A significant increase in ucfDNA fragment ends within DHSs was observed in Dnase1-deficient mice.
  • Patients with bladder cancer showed a lower proportion of ucfDNA fragment ends within DHSs compared to healthy individuals, with an AUC of 0.83 for differentiation.

Conclusions:

  • DNASE1 is a key nuclease responsible for ucfDNA fragmentation in urine.
  • The fragmentation patterns of ucfDNA, specifically the proportion of fragment ends within DHSs, represent a promising biomarker for non-invasive bladder cancer detection.